Hypertrophic cardiomyopathy: Difference between revisions
(Created page with "'''Hypertrophic cardiomyopathy''' (<abbr>HCM</abbr>) is a form of cardiomyopathy characterised by left ventricular hypertrophy in the absence of a provoking disease like hypertension or aortic stenosis. The hypertrophy is often asymmetric. '''Hypertrophic obstructive cardiomyopathy''' (HOCM) is a subtype of HCM characterised by obstruction of the left ventricular outflow tract due to excessive hypertrophy of the ventricular septum. It’s a common cause of...") |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
'''Hypertrophic cardiomyopathy''' (<abbr>HCM</abbr>) is a form of [[cardiomyopathy]] characterised by left ventricular hypertrophy in the absence of a provoking disease like [[hypertension]] or [[aortic stenosis]]. The hypertrophy is often asymmetric. | <section begin="radiology" />'''Hypertrophic cardiomyopathy''' (<abbr>HCM</abbr>) is a form of [[cardiomyopathy]] characterised by left ventricular hypertrophy in the absence of a provoking disease like [[hypertension]] or [[aortic stenosis]]. The hypertrophy is often asymmetric. | ||
'''Hypertrophic obstructive cardiomyopathy''' (HOCM) is a subtype of HCM characterised by obstruction of the left ventricular outflow tract due to excessive hypertrophy of the ventricular septum. | '''Hypertrophic obstructive cardiomyopathy''' (HOCM) is a subtype of HCM characterised by obstruction of the left ventricular outflow tract due to excessive hypertrophy of the ventricular septum.<section end="radiology" /> | ||
It’s a common cause of [[sudden cardiac death]], especially in athletes. It may also progress into left ventricular dilation. It’s the second most common CMP, affecting 1/500. | It’s a common cause of [[sudden cardiac death]], especially in athletes. It may also progress into left ventricular dilation. It’s the second most common CMP, affecting 1/500. | ||
| Line 17: | Line 17: | ||
For some affected people, [[sudden cardiac death]] is the first manifestation of HCM. | For some affected people, [[sudden cardiac death]] is the first manifestation of HCM. | ||
<section begin="radiology" /> | |||
== Diagnosis and evaluation == | == Diagnosis and evaluation == | ||
[[Echocardiography|ECG]] shows signs of left ventricular hypertrophy and strain. [[Echocardiography]] shows left ventricular hypertrophy, a septum which is thicker than the posterior wall, normal LV chamber size. SAM may also be visualised. | [[Echocardiography|ECG]] shows signs of left ventricular hypertrophy and strain. [[Echocardiography]] shows left ventricular hypertrophy, a septum which is thicker than the posterior wall, normal LV chamber size. SAM may also be visualised. | ||
[[Magnetic resonance imaging|MRI]] is the gold standard for the evaluation. 1st degree relatives should be screened for the condition. | [[Magnetic resonance imaging|MRI]] is the gold standard for the evaluation. 1st degree relatives should be screened for the condition. | ||
<section end="radiology" /> | |||
== Treatment == | == Treatment == | ||
There’s no specific treatment. Strenuous physical activity should be avoided to prevent [[sudden cardiac death]]. In case of significant LVOT obstruction, medical treatment is indicated, but it’s not certain whether medical treatment is indicated for HCM without significant LVOT obstruction. Medical treatment includes [[Beta blocker|beta blockers]], [[Calcium channel blocker|CCBs]], and [[Antiarrhythmic drug|antiarrhythmic drugs]]. | There’s no specific treatment. Strenuous physical activity should be avoided to prevent [[sudden cardiac death]]. In case of significant LVOT obstruction, medical treatment is indicated, but it’s not certain whether medical treatment is indicated for HCM without significant LVOT obstruction. Medical treatment includes [[Beta blocker|beta blockers]], [[Calcium channel blocker|CCBs]], and [[Antiarrhythmic drug|antiarrhythmic drugs]]. | ||
| Line 29: | Line 29: | ||
Procedures to reduce the size of the septum may also be used, and include surgical septal myectomy, and the use of alcohol to ablate the septum. Heart transplant is a last-line option. | Procedures to reduce the size of the septum may also be used, and include surgical septal myectomy, and the use of alcohol to ablate the septum. Heart transplant is a last-line option. | ||
<noinclude> | |||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category:Internal Medicine (POTE course)]] | |||
</noinclude> | |||
Latest revision as of 13:16, 28 November 2023
Hypertrophic cardiomyopathy (HCM) is a form of cardiomyopathy characterised by left ventricular hypertrophy in the absence of a provoking disease like hypertension or aortic stenosis. The hypertrophy is often asymmetric.
Hypertrophic obstructive cardiomyopathy (HOCM) is a subtype of HCM characterised by obstruction of the left ventricular outflow tract due to excessive hypertrophy of the ventricular septum.
It’s a common cause of sudden cardiac death, especially in athletes. It may also progress into left ventricular dilation. It’s the second most common CMP, affecting 1/500.
Etiology
HCM is a genetic disorder, most commonly caused by mutations in sarcomeric proteins like myosin. Inheritance is autosomal dominant with varying penetrance.
Pathomechanism
HCM causes diastolic dysfunction and increased filling pressure. During systole, there is a narrowing of the LV outflow tract and increased ejection speed. This increased ejection speed decreases the pressure in this region, causing the anterior leaflet of the mitral valve to be pulled in that direction. This is called systolic anterior motion (SAM) of the anterior cusp of the mitral valve, which can intermittently obstruct the outflow tract, causing a sudden decrease in CO. This phenomenon occurs more frequently during exercise.
HCM predisposes to development of arrhythmias, including fatal ones.
Clinical features
Many are asymptomatic. Possible symptoms include dyspnoea, angina pectoris, and syncope (due to LVOT obstruction).
For some affected people, sudden cardiac death is the first manifestation of HCM.
Diagnosis and evaluation
ECG shows signs of left ventricular hypertrophy and strain. Echocardiography shows left ventricular hypertrophy, a septum which is thicker than the posterior wall, normal LV chamber size. SAM may also be visualised.
MRI is the gold standard for the evaluation. 1st degree relatives should be screened for the condition.
Treatment
There’s no specific treatment. Strenuous physical activity should be avoided to prevent sudden cardiac death. In case of significant LVOT obstruction, medical treatment is indicated, but it’s not certain whether medical treatment is indicated for HCM without significant LVOT obstruction. Medical treatment includes beta blockers, CCBs, and antiarrhythmic drugs.
Prevention of SCD by ICD implantation is generally indicated but depends on the patients calculated risk.
Procedures to reduce the size of the septum may also be used, and include surgical septal myectomy, and the use of alcohol to ablate the septum. Heart transplant is a last-line option.